We are live on ! Find out more
ICM

Invenomic Capital Management Portfolio holdings

AUM $2.18B
1-Year Est. Return 0.03%
This Fund
S&P 500
This Quarter Est. Return
+5.39%
1 Year Est. Return
+0.03%
3 Year Est. Return
-6.37%
5 Year Est. Return
-25.27%
10 Year Est. Return
–
AUM
$2.07B
AUM Growth
+$304M
Cap. Flow
+$228M
Cap. Flow %
11.06%
Top 10 Hldgs %
26.72%
Holding
186
New
38
Increased
42
Reduced
61
Closed
43

Top Buys

Rank Stock Value
1
HAE icon
Haemonetics
HAE
+$29.1M
2
FUN icon
Cedar Fair
FUN
+$27.5M
3
DV icon
DoubleVerify
DV
+$26.8M
4
CNMD icon
CONMED
CNMD
+$21.8M
5
XRAY icon
Dentsply Sirona
XRAY
+$20.7M

Top Sells

Rank Stock Value
1
AAP icon
Advance Auto Parts
AAP
+$29.3M
2
NGD
New Gold Inc
NGD
+$20.9M
3
WBD icon
Warner Bros
WBD
+$20.7M
4
VRNT
Verint Systems
VRNT
+$19.9M
5
M icon
Macy's
M
+$17.3M

Sector Composition

Rank Sector Weight
1 Technology 20.05%
2 Healthcare 18.45%
3 Consumer Discretionary 15.14%
4 Materials 10.18%
5 Industrials 8.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BTG icon
101
B2Gold
BTG
$6.68B
$4.9M 0.24%
990,484
+252,092
+34% +$991K
TCMD icon
102
Tactile Systems Technology
TCMD
$657M
$4.89M 0.24%
353,657
-18,230
-5% -$219K
DOW icon
103
Dow Inc
DOW
$22.1B
$4.84M 0.23%
+211,020
New +$5.26M
OEC icon
104
Orion
OEC
$389M
$4.81M 0.23%
635,158
+85,800
+16% +$867K
VTOL icon
105
Bristow Group
VTOL
$1.38B
$4.78M 0.23%
132,596
+18,003
+16% +$661K
JHX icon
106
James Hardie Industries
JHX
$17.7B
$4.69M 0.23%
+243,929
New +$5.84M
MG icon
107
Mistras Group
MG
$502M
$4.65M 0.23%
+472,536
New +$4.2M
GNRC icon
108
Generac Holdings
GNRC
$12.2B
$4.65M 0.23%
27,763
-46,603
-63% -$8.16M
CENX icon
109
Century Aluminum
CENX
$5.14B
$4.56M 0.22%
+155,269
New +$3.52M
LSPD icon
110
Lightspeed Commerce
LSPD
$1.36B
$4.46M 0.22%
386,259
-20,645
-5% -$253K
MLR icon
111
Miller Industries
MLR
$606M
$4.44M 0.22%
+109,900
New +$4.63M
HSII
112
DELISTED
Heidrick & Struggles
HSII
$4.39M 0.21%
88,176
-168,080
-66% -$8.1M
RGNX icon
113
Regenxbio
RGNX
$688M
$4.12M 0.2%
+426,904
New +$3.78M
RYZ
114
Ryerson Holding Corp
RYZ
$1.45B
$4.03M 0.2%
+176,376
New +$3.97M
HLF icon
115
Herbalife
HLF
$1.21B
$3.55M 0.17%
+420,630
New +$3.97M
KMX icon
116
CarMax
KMX
$8.34B
$3.52M 0.17%
+78,349
New +$4.68M
COUR icon
117
Coursera
COUR
$1.52B
$3.45M 0.17%
294,899
-991,934
-77% -$10.8M
JILL icon
118
J. Jill
JILL
$279M
$3.43M 0.17%
+200,066
New +$3.3M
SNBR
119
DELISTED
Sleep Number
SNBR
$3.41M 0.17%
+485,966
New +$4.25M
RGP icon
120
Resources Connection
RGP
$145M
$3.3M 0.16%
653,308
-34,920
-5% -$179K
SPT icon
121
Sprout Social
SPT
$604M
$3.21M 0.16%
248,636
-13,290
-5% -$217K
CLW icon
122
Clearwater Paper
CLW
$368M
$3.12M 0.15%
+150,332
New +$3.63M
FORR icon
123
Forrester Research
FORR
$221M
$2.8M 0.14%
264,613
-14,143
-5% -$143K
ATNI icon
124
ATN International
ATNI
$494M
$2.75M 0.13%
183,505
-9,753
-5% -$161K
AVD icon
125
American Vanguard Corp
AVD
$65.5M
$2.6M 0.13%
453,371
-24,232
-5% -$116K
3 4
5
6 7

Similar funds

SIG
Senator Investment Group New York $2.18B AUM 58.56% 1-Year Est. Return
ORCP
One Rock Capital Partners New York $2.19B AUM
ET
Entropy Technologies New York $2.17B AUM 21.46% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
MIAS
Mason Investment Advisory Services Reston, Virginia $2.17B AUM 28.39% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
IIP
Intermede Investment Partners London, United Kingdom $2.16B AUM 18.47% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return

Invenomic Capital Management's Q3 2025 Portfolio in Review

As of Q3 2025, Invenomic Capital Management held 186 positions worth $2.07B, up 17% from $1.76B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Invenomic Capital Management deployed $228M of net new capital in Q3 2025, opening 38 new positions and adding to 42 existing holdings. Its largest new stake was Cedar Fair: 1,034,288 shares worth $23.5M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Warner Bros, an estimated $20.7M trimmed.

  • Invenomic Capital Management's largest Q3 2025 buy was Cedar Fair: 1,034,288 shares worth $23.5M.
  • Invenomic Capital Management added most to Haemonetics in Q3 2025, an estimated $29.1M increase.
  • Invenomic Capital Management's biggest Q3 2025 reduction was Warner Bros, cutting an estimated $20.7M.
  • Invenomic Capital Management fully exited Advance Auto Parts in Q3 2025, selling an estimated $29.3M.
  • Invenomic Capital Management's ten largest holdings make up 27% of its $2.07B portfolio in Q3 2025.
  • Invenomic Capital Management opened 38 new positions and closed 43 in Q3 2025.
  • Invenomic Capital Management's portfolio value rose 17% quarter-over-quarter to $2.07B.

Based on Invenomic Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.